RecruitingNot Applicable

Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.

France2,000 participantsStarted 2022-10-01

Plain-language summary

The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 40 years old
✓. COPD documented or strongly suspected
✓. Severe acute exacerbation, defined as a worsening of the patient's usual respiratory symptoms with signs of acute respiratory distress (polypnoea ≥ 30 cycles.min-1 or use of accessory respiratory muscles) and/or hypercapnic acidosis (with PaCO2 ≥ 45 mmHg and pH ≤ 7.35)
✓. Admission to an ICU, a step-up unit or a respiratory care unit

Exclusion criteria

✕. Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines)
✕. Patient refusal to participate (information note, application for non-opposition)

What they're measuring

the epidemiological, clinical and biological characteristics of patients admitted to the ICU for a severe acute exacerbation of COPD

Timeframe: 5 year

Trial details

NCT IDNCT06257329

SponsorAlexis FERRE

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-10-01

Contact for this trial

alexis ferre

+33.1.39.63.88.37 aferre@ght78sud.fr

View on ClinicalTrials.gov More COPD Exacerbation trials